About Endoskeleton® TA ALIF Device (Prod 9782)
The Endoskeleton® TA ALIF Interbody Fusion Device is approved for use in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2-S1. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved level(s). Patients should have received six months of non-operative treatment prior to treatment with the devices. The device may be used with supplemental fixation. The Endoskeleton TA ALIF Device sits on the strongest portion of the endplate yielding excellent resistance to subsidence.The manufacturer is offering a warranty and through the warranty, the manufacturer provides a one-time free replacement of any eligible Endoskeleton spinal interbody fusion device if revision surgery is required within the five year warranty period, as outlined within the terms of the agreement.
OrthopaedicLIST.com is a list of products and services. Every effort is made to keep this listing as accurate and current as possible. Companies and individuals are encouraged to notify us of errors and omissions. We will respond to such messages of correction in a timely fashion, as our workload permits.
We are non-judgmental of products listed. We are not in the business of evaluating products. We have not evaluated these products. We make no representations as to the quality, effectiveness, suitability or appropriateness of any of the products listed.
As an important component of the service function of OrthopaedicLIST.com, some products continue to be listed that are no longer manufactured and may not be available. We will identify them as such when possible. This allows users to find special instruments and/or components for removal, modification, and/or revision of those products.